[Therapeutic possibilities of the use of structural neurophospholipids in premature infants. (Clinical evaluation of neurologic function at the end of 1st semester of life)].
D001238:Asphyxia Neonatorum / Q000188:drug therapy; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001925:Brain Damage, Chronic / Q000188:drug therapy*; D002463:Cell Membrane Permeability; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007567:Jaundice, Neonatal / Q000188:drug therapy; D008564:Membrane Potentials; D010743:Phospholipids / Q000627:therapeutic use*
D010743:Phospholipids
Possibilità terapeutiche dell'impiego di neurofosfolipidi strutturali nell'immaturo. (Valutazione clinica della funzionalità neurologica alla fine del primo semestre di vita0.